BRISTOL MYERS SQUIBB CO (BMY) Options Risk Score
Real-time risk analysis for BMY options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full BMY options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan BMY Now — Free →
Is it risky to sell options on BRISTOL MYERS SQUIBB CO (BMY) right now?
For a 4-week expiry, BRISTOL MYERS SQUIBB CO (BMY) carries an options catalyst-risk score of 88 out of 100 (HIGH). That score is driven by an upcoming earnings report, 6 active legal filings and 29 clinical-trial catalysts falling inside the 4-week window. Anything at 70 or above counts as HIGH, meaning the premium on BMY is at least partly compensation for a scheduled event rather than pure time value. It says nothing about direction — only that something is on the calendar.
BMY shows an IV Rank of 77 — implied volatility is near the top of its own one-year range, so BMY options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 36%. IV Rank is the most useful figure for deciding whether to sell or buy premium on BMY.
BMY reports on 2026-07-30. Any expiry beyond that date carries the gap, and the implied volatility priced in beforehand typically collapses the morning after.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer